Hepatorenal Syndrome

Crit Care Clin. 2021 Apr;37(2):321-334. doi: 10.1016/j.ccc.2020.11.011. Epub 2020 Dec 15.

Abstract

Development of acute kidney injury in patients with chronic liver disease is common and portends a poor prognosis. Diagnosis remains challenging, as traditional markers, such as serum creatinine, are not reliable. Recent development of novel biomarkers may assist with this. Pathophysiology of this condition is multifactorial, relating to physiologic changes associated with portal hypertension, kidney factors, and systemic inflammatory response. Mainstay of treatment remains use of vasoconstrictors along with albumin. Recent guidelines streamline the selection of patients that will require simultaneous liver and kidney transplantation. Posttransplant kidney injury is common relating to multiple factors.

Keywords: Acute kidney injury; Acute on chronic liver failure; Biomarkers; Cirrhosis; Hepatorenal syndrome; Liver transplantation; Model end-stage liver disease; Simultaneous liver kidney transplantation.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury* / diagnosis
  • Acute Kidney Injury* / etiology
  • Acute Kidney Injury* / therapy
  • Creatinine
  • Hepatorenal Syndrome* / diagnosis
  • Hepatorenal Syndrome* / etiology
  • Hepatorenal Syndrome* / therapy
  • Humans
  • Hypertension, Portal* / diagnosis
  • Hypertension, Portal* / etiology
  • Hypertension, Portal* / therapy
  • Liver Cirrhosis

Substances

  • Creatinine